Metocal is a medication that increases the motility of stomach and upper intestine. It is primarily used to treat digestive disorders, such as nausea and vomiting, in addition to being used in various diagnostic procedures.

Metocal is available in several pharmaceutical forms, including injectable ampoules for intramuscular or intravenous administration as well as oral tablets.

Each 2 mL of Metocal ampoule contains 10 mg Metoclopramide HCl.

Metocal ampoules are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis.

Metocal ampoules can be used to treat gastroesophageal reflux disease (GERD).

Metocal ampoules are indicated for the treatment of sudden and uncontrolled contractions of the diaphragm muscle (hiccups).

Metocal ampoules are used for the prophylaxis of nausea and vomiting associated with emetogenic cancer radiotherapy or chemotherapy.

Metocal ampoules are effective for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.

Metocal ampoules are considered an ideal choice for the prophylaxis of nausea and vomiting associated with acute migraine.

Metocal ampoules may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers.

Metocal ampoules may be used to stimulate the emptying of the gastrointestinal tube prior to radiological examination.

Children:

Due to the risk of extrapyramidal symptoms, the use of Metocal in children and adolescent (between 1 year of age to 18 years of age) is limited to certain conditions and is considered second-line therapy.

Pregnancy& breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Metocal.

Pregnancy Category: B.

Metocal should not be used whilst breastfeeding because of small amounts Metocal appear in breast milk, and affect your baby.

Diabetic Gastroparesis:

if severe symptoms are present, therapy should begin with Metocal ampoules (I.M. or I.V.).

Metocal ampoules may be administered slowly by the intravenous route over a period of 1 to 2 minutes.

The prevention of nausea and vomiting associated with emetogenic cancer radiotherapy or chemotherapy:

Metocal ampoules should be administered slowly over a period not less than 15 minutes, 30 minutes before beginning cancer chemotherapy.

The prevention of postoperative nausea and vomiting:

Metocal ampoules should be given intramuscularly near the end of surgery. The recommended adult dose is one ampoule; however, doses of 2 ampoule may be used.

Small bowel intubation:

The recommended dose of Metocal is one ampoule (For children above 14 years of age and adults).

The recommended dose of Metocal is ¼ - ½ ampoule (For children between 6 to 14 years of age).

The recommended dose of Metocal is 0.1 mg/kg (For children under 6 years of age).

Stimulate the emptying of the gastrointestinal tube prior to radiological examination:

A single dose of Metocal ampoules may be administered slowly by the intravenous route over a period of 1 to 2 minutes.